Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Capri Holdings | CPRI | Oct 30, 2024 | 19.46 | -4.98 |
Capricor Therapeutics | CAPR | Oct 30, 2024 | 21.36 | -2.86 |
Captivision | CAPT | Oct 30, 2024 | 1.44 | -7.10 |
Cara Therapeutics | CARA | Oct 30, 2024 | 0.29 | +8.28 |
Caravelle International Group | CACO | Oct 30, 2024 | 0.44 | 0.00 |
Carbon Revolution | CREV | Oct 30, 2024 | 3.47 | -2.37 |
Cardiff Oncology | CRDF | Oct 30, 2024 | 3.12 | 0.00 |
Cardinal Health | CAH | Oct 30, 2024 | 107.89 | -1.97 |
Cardio Diagnostics | CDIO | Oct 30, 2024 | 0.25 | -2.51 |
Cardiol Therapeutics | CRDL | Oct 30, 2024 | 1.82 | -0.55 |
Cardlytics | CDLX | Oct 30, 2024 | 4.14 | +3.76 |
CareCloud | CCLD | Oct 30, 2024 | 2.34 | +0.86 |
CareCloud A Pref | CCLDP | Oct 30, 2024 | 12.20 | -0.85 |
CareCloud B Pref | CCLDO | Oct 30, 2024 | 12.47 | +0.97 |
CareDx | CDNA | Oct 30, 2024 | 22.98 | +1.68 |
CareMax A | CMAX | Oct 30, 2024 | 2.02 | +32.03 |
CareTrust REIT | CTRE | Oct 30, 2024 | 32.81 | +2.79 |
CARGO Therapeutics | CRGX | Oct 30, 2024 | 21.16 | -6.08 |
CarGurus A | CARG | Oct 30, 2024 | 31.53 | +0.25 |
Caribou Biosciences | CRBU | Oct 30, 2024 | 1.97 | +2.07 |
Carisma Therapeutics | CARM | Oct 30, 2024 | 1.00 | -0.99 |
Carlisle Companies | CSL | Oct 30, 2024 | 422.16 | +0.77 |
Carlyle Credit Income Fund | CCIA | Oct 30, 2024 | 25.75 | -0.04 |
Carlyle Credit Income Fund | CCIF | Oct 30, 2024 | 8.20 | -0.12 |
Carlyle Secured Lending | CGBD | Oct 30, 2024 | 17.15 | -0.06 |
CarMax | KMX | Oct 30, 2024 | 74.05 | +0.46 |
Carmell | CTCX | Oct 30, 2024 | 0.35 | +4.52 |
Carnival | CCL | Oct 30, 2024 | 22.16 | +0.27 |
Carnival ADR | CUK | Oct 30, 2024 | 20.08 | 0.00 |
CarParts.com | PRTS | Oct 30, 2024 | 0.83 | +11.77 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.